FDA Drug Application (207266) for BUPIVACAINE HYDROCHLORIDE by CLARIS

Back to FDA Applications sponsored by CLARIS

Application Number207266
Product Number001
FormINJECTABLE;SPINAL
Dosage0.75%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameBUPIVACAINE HYDROCHLORIDE
Active IngredientBUPIVACAINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient BUPIVACAINE HYDROCHLORIDE12


Back to FDA Applications sponsored by CLARIS